-
Google PR 0Trustworthiness Unknown
-
Avg. Daily Visitors N/AChild Safety Unknown
-
Avg. Daily Pageviews N/APrivacy Unknown
InvestorRoom D - News Releases
Domain info
Location: | United States |
Registrant: | Not Disclosed Not Disclosed (Not Disclosed) |
Hosted by: | CloudFlare, Inc. |
Registrar: | CSC Corporate Domains, Inc. |
Subnetworks: | 104.17.202.159, 104.17.203.159, 104.17.204.159, 104.17.205.159, 104.17.206.159 |
Social Media Activities
- Facebook likes: -
- Twitter mentions: -
- Google pluses: -
- LinkedIn mentions: -
- Pinterest pins: -
- StumbleUpon views: -
Web Safety
- This website is malware-free.
- Status ok
Sites associated with the same registrant
Whois
Immunepharmaceuticals.investorroom.com popular pages to visit
New Data Suggests Improved Tumor Response For The Combination of AZIXA® and Immune Checkpoint Inhibitors in The Treatment of
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and R...
Immune Pharmaceuticals Provides Business and R&D Update and Announces First Quarter 2016 Financial Results - May 16, 2016
Immune Pharmaceuticals Provides Business and R&D Update and Announces First Quarter 2016 Financial Results
May 16, 2016
NEW YORK, May 16, 2016 /PRNewswire/ --Â Immune Pharmaceuticals Inc. (NASDAQ: IMN...
Immune Pharmaceuticals Announces Exclusive License to a Novel Bispecific Antibody Technology - Dec 28, 2015
Immune Pharmaceuticals Announces Exclusive License to a Novel Bispecific Antibody Technology
New technology will allow for the development of innovative drug candidates targeting immune checkpoints
De...